Congratulations to the entire team at CroiValve!
Is there a better way to treat patients with severe+ tricuspid regurgitation? We are excited to announce the first US patient treated with the DUO™ System as part of the TANDEM II Early Feasibility Study. The DUO™ System is a novel transcatheter valve that works in tandem with the native tricuspid valve to restore valve function while preserving the native valve apparatus. "The DUO™ System offers a unique benefit for patients suffering from TR as the device is designed to treat a broad patient population. The procedure is straightforward, leveraging standard interventional techniques and has the potential to accelerate transcatheter tricuspid therapy adoption by more physicians due to the system’s simplicity and scalability." Vinod Thourani Pradeep Yadav https://lnkd.in/gK9PfZg5 #CroiValve #DUO System #Tricuspid Regurgitation Learn more about the DUO System: https://croivalve.com Caution: The DUO System is an investigational device and not for sale in any geography.